OvaScience Reports AUGMENT Treatment Shows Improved Pregnancy Rates, Live Births in Women with Poor Prognoses

By: via Benzinga
OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.